E
Sell
6/25/2024Downgrade
Treatment.com AI Inc. (TRUE) was downgraded to E+ from D- on 6/25/2024 due to a decline in the volatility index and total return index.
D
Sell
6/5/2024Upgraded
Treatment.com AI Inc. (TRUE) was upgraded to D- from E+ on 6/5/2024 due to an increase in the valuation index.
E
Sell
5/14/2024Downgrade
Treatment.com AI Inc. (TRUE) was downgraded to E+ from D- on 5/14/2024 due to a decline in the volatility index.
D
Sell
4/26/2024Upgraded
Treatment.com AI Inc. (TRUE) was upgraded to D- from E+ on 4/26/2024 due to a large increase in the solvency index, total return index and volatility index. The quick ratio increased from 0 to 0.54, and debt to equity declined from -0.25 to -0.92.
E
Sell
3/14/2023Downgrade
Treatment.Com International Inc. (TRUE) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
1/27/2023Upgraded
Treatment.Com International Inc. (TRUE) was upgraded to D- from E+ on 1/27/2023 due to a substantial increase in the growth index, valuation index and volatility index. Operating cash flow increased 73.89% from -$299.9 to -$78.3, EBIT increased 42.86% from -$468.3 to -$267.6, and earnings per share increased from -$0.0072 to -$0.0043.
E
Sell
6/23/2022Upgraded
Treatment.Com International Inc. (TRUE) was upgraded to E+ from E on 6/23/2022 due to an increase in the volatility index and valuation index.
E
Sell
6/8/2022Downgrade
Treatment.Com International Inc. (TRUE) was downgraded to E from E+ on 6/8/2022 due to a decline in the volatility index, efficiency index and solvency index. Net income declined 105.19% from -$1.83M to -$3.75M, total capital declined 60.45% from $3.37M to $1.33M, and the quick ratio declined from 6.09 to 2.92.
E
Sell
1/3/2022Upgraded
Treatment.Com International Inc. (TRUE) was upgraded to E+ from E on 1/3/2022 due to an increase in the valuation index.
E
Sell
11/3/2021None
Treatment.com AI Inc. (TRUE) was downgraded to E from U on 11/03/2021.
